Alder BioPharmaceuticals (ALDR) Misses Q1 EPS by 1c

Alder BioPharmaceuticals (NASDAQ: ALDR) reported Q1 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Alder BioPharmaceuticals (ALDR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c